FDA inspection
Sinsin Pharmaceutical Co., Ltd.: FDA inspection ending Nov 24, 2017
FDA inspection 1036107 · Voluntary Action Indicated (VAI) · Sejong
Key facts
| Inspection ID | 1036107 |
|---|---|
| Firm | Sinsin Pharmaceutical Co., Ltd. |
| FEI number | 3002277609 |
| Address | 141 Beon-Gil, Danwon |
| City | Sejong |
| Country | Korea (the Republic of) |
| Fiscal year | 2018 |
| Inspection end date | Nov 24, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data